Skip to main content

Table 3 Serum hormones in patients and control group according to score on the Beck Depression Inventory (BDI)a

From: Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones

 

Patients with fibromyalgia

Patients with CFS

Healthy controls

 

BDI < 17 (N = 32)

BDI ≥ 17 (N = 36)

BDI < 17 (N = 21)

BDI ≥ 17 (N = 41)

(N = 46)

Age (years)

31.86 ± 7.29

30.65 ± 7.65

31.98 ± 6.57

32.76 ± 7.18

31.54 ± 6.86

LH

11.65 ± 10.42* & #

6.43 ± 4.28

6.21 ± 7.26

6.71 ± 5.87

6.88 ± 4.69

FSH

7.13 ± 3.21

6.25 ± 2.84

5.87 ± 3.69

6.81 ± 4.43

6.69 ± 4.87

Progesterone

4.19 ± 4.56

4.73 ± 5.56

4.18 ± 4.65

3.72 ± 5.27

3.78 ± 3.97

Estradiol

113.48 ± 69.45

121.42 ± 90.26

98.39 ± 87.11

107.23 ± 91.57

94.15 ± 59.34

Prolactin

26.08 ± 32.19

21.03 ± 11.32

23.41 ± 28.49

20.87 ± 27.36

19.35 ± 10.45

Cortisol

11.94 ± 6.56#

10.11 ± 5.67*

8.96 ± 4.28*

10.52 ± 5.45*

13.52 ± 6.25

  1. Values are means ± standard deviation. aA BDI score of ≥ 17 was considered to indicate depression. *Significantly different from control (P < 0.05); &significantly different from fibromyalgia group with BDI ≥ 17 (P < 0.05); #significantly different from CFS group with BDI < 17 (P < 0.05). CFS, chronic fatigue syndrome; FSH, follicle-stimulating hormone; LH, luteinizing hormone.